SEC Comment Letter 0000000000-23-003410 to WEARABLE HEALTH SOLUTIONS, INC. (WHSI) (CIK 0001443089)
WEARABLE HEALTH SOLUTIONS, INC. (WHSI) (CIK 0001443089)
Date: April 5, 2023 · CIK: 0001443089 · Accession: 0000000000-23-003410
AI Filing Summary & Sentiment
File numbers found in text: 024-12202
Letter
United States securities and exchange commission logo April 5, 2023 Peter Pizzino President Wearable Health Solutions, Inc. 2901 Pacific Coast Highway, Suite 200 Newport Beach, CA 92663 Re:Wearable Health Solutions, Inc. Offering Statement on Form 1-A Filed on March 30, 2023 File No. 024-12202 Dear Peter Pizzino: This is to advise you that we do not intend to review your offering statement. We will consider qualifying your offering statement at your request. If a participant in your offering is required to clear its compensation arrangements with FINRA, please have FINRA advise us that it has no objections to the compensation arrangements prior to qualification. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. We also remind you that, following qualification of your Form 1-A, Rule 257 of Regulation A requires you to file periodic and current reports, including a Form 1-K which will be due within 120 calendar days after the end of the fiscal year covered by the report. Please contact Jenny O'Shanick at 202-551-8005 with any questions. Sincerely, Division of Corporation Finance Office of Manufacturing cc: Jonathan D. Leinwand, P.A.
Show Raw Text
United States securities and exchange commission logo
April 5, 2023
Peter Pizzino
President
Wearable Health Solutions, Inc.
2901 Pacific Coast Highway, Suite 200
Newport Beach, CA 92663
Re:Wearable Health Solutions, Inc.
Offering Statement on Form 1-A
Filed on March 30, 2023
File No. 024-12202
Dear Peter Pizzino:
This is to advise you that we do not intend to review your offering statement.
We will consider qualifying your offering statement at your request. If a participant in
your offering is required to clear its compensation arrangements with FINRA, please have
FINRA advise us that it has no objections to the compensation arrangements prior to
qualification.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff. We also remind you that, following qualification of your Form 1-A, Rule 257
of Regulation A requires you to file periodic and current reports, including a Form 1-K which
will be due within 120 calendar days after the end of the fiscal year covered by the report.
Please contact Jenny O'Shanick at 202-551-8005 with any questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing
cc: Jonathan D. Leinwand, P.A.